tci Medicare Compliance & Reimbursement - 2005 Issue 13

LABS: CMS Alters C-Peptide Test Requirement

Lower limit is key.For services performed on or after Dec. 17, 2004, a positive fasting beta cell autoantibody test can serve as an alternative to insulinopenia for the updated C-peptide testing requirement, the Centers for Medicare and Medicaid Services said Feb. 10.Insulinopenia is a fasting C-peptide level less than or equal to 110 percent of the lower limit of normal. Patients with renal insufficiency must have a fasting C-peptide level that is less than or equal to 200 percent of the lower limit. The "lower limit" is contingent on the laboratory's measurement method. To read more...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.